Ageing: A risk factor for amyloid A amyloidosis in rheumatoid arthritis

Amyloid

Volumn 18, Issue 3, 2011, Pages 108-111

  Okuda, Yasuaki ^a   Yamada, Toshiyuki ^b   Matsuura, Masaaki ^c   Takasugi, Kiyoshi ^a   Goto, Makoto ^d  

^a Dohgo Spa Hospital   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c CANCER INSTITUTE   (Japan)

^d TOIN UNIVERSITY OF YOKOHAMA   (Japan)

Author keywords

Ageing; Amyloid A amyloidosis; Rheumatoid arthritis

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; SERUM AMYLOID A;

ADULT; AGING; AMYLOID A AMYLOIDOSIS; AMYLOIDOSIS; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE;

AGING; ALLELES; AMYLOIDOSIS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; EXONS; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM AMYLOID A PROTEIN; SEX FACTORS;

EID: 80052201333     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.582198     Document Type: Article

References (23)

1. Gillmore JD, Lovat L, Persey MR, Pepys M, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid protein. Lancet 2001;358:24-29. (Pubitemid 32709735)
2. Yamada T. Serum Amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999;37:381-388. (Pubitemid 29218956)
3. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida K, Aoyagi K, Iwashita A, Daimaru Y, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-49.
4. Okuda Y, Yamada T, Takasugi K, Takeda M, Namba S, Onishi M, Miyamoto T, Inoue Y. Serum amyloid A (SAA)1, SAA2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis. Rhumachi 1999;39:3-10. (Pubitemid 29166236)
5. Liepnieks JJ, Kluve-Beckerman B, Benson MD. Characterization of Amyloid A protein in human secondary amyloidosis. The predominance deposition of serum amyloid A1. Biochim Biophys Acta 1995;1270:81-86.
6. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H. A novel allelic variant serum amyloid A. SAA1: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995;4:1083-1087.
7. Moriguchi M, Terai C, Koseki Y, Uesato A, Nakajima A, Inada S, Uchida A, Nakajima A, Kim SY. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999;105: 360-366. (Pubitemid 29476289)
8. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary rheumatoid arthritis. Rheumatology 2006;45:43-49. (Pubitemid 43033873)
9. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998;5:262-265. (Pubitemid 128690765)
10. Hus HC, Zhon T, Yang PA, Herrera GA, Mountz JD. Increased acutephase response and renal amyloidosis in aged CD2-fas-transgenic mice. J Immunol 1997;158:5988-5996. (Pubitemid 127484008)
11. Yokota T, Ishihara T, Kawano H, Takahashi M, Fujinaga Y, Uchino F. Amyloid enhancing factor (AEF) in the aging mouse. Virchows Arch A Pathol Anat Histopathol 1989;414: 511-514. (Pubitemid 19148289)
12. Okuda Y, Takasugi K. Diagnostic and prognostic study of secondary amyloidosis complicating rheumatoid arthritis. In: Kyle RA, Gertz MA, editors. Amyloid and Amyloidosis. New York: Parthenon Publishing Group; 1998. pp 426-428.
13. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324. (Pubitemid 18091653)
14. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-364.
15. Linke RP. Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem 1984;32:322-328. (Pubitemid 14151397)
16. Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. Amyloid 1999;6:199-204. (Pubitemid 29483012)
17. Lachmann HJ, Goodman HJB, Gilbertson JA, Gilimore JR, Sabin CA, Gillmore JD, Hawkins PH. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361-2371. (Pubitemid 46883770)
18. Falsey AR, Walsh EE, Francis CW, Looney RJ, Kolassa JE, Hall WJ, Abraham GN. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis 2001;183:995-999. (Pubitemid 32230945)
19. Rosenthal CJ, Franklin EC. Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest 1975;55:746-753.
20. Goto M. Inflammageing (inflammation-aging):a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? BioScience Trend 2008;2:218-230.
21. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. The association of C-reactive protein, serum amyloid A and fibrinogen with prevalent coronary heart disease-baseline findings of PAIS project. Atherosclerosis 2001;156:451-456. (Pubitemid 32522927)
22. Westermark P, Sletten K, Johnson KH. Ageing and amyloid fibrillogenesis: lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide. Ciba Found Symp. 1996;199: 205-218.
23. Buxbaum J, Koziol J, Conners LH. Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity. Amyloid 2008;15:255-261.